20223 min read
Medical Article
The initial treatment of non-small cell lung cancer consists of platinum-based chemotherapy. Chemotherapy along with immunotherapy induces immunogenic cell death and sustained long-term response. The American Society of Clinical Oncology (ASCO) 2022 guidelines provide evidence-based recommendations for treating stage IV non-small-cell lung cancer.

ASCO 2022 Systemic Therapy Guidelines for Patients with Stage IV Non–Small-Cell Lung Cancer
1728 Reached2 Comments
Similar Content

Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments

Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes

Case of Pulmonary Embolism with Syncope
544 Reached4 Likes

Black Lesion in Old Female
1974 Reached5 Comments11 Likes

Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
1008 Reached2 Comments
